Sanofi to Invest $400 Million in Expanding Hyderabad Global Capacity Centre

Sanofi to inject €400 million by 2030 to expand its largest GCC in Hyderabad; to ramp up headcount to 2,600 by 2026 - Times of India

HYDERABAD: French biopharma giant Sanofi is injecting Euro 400 million (approx Rs 3,600 crore) in expanding its largest global capability centre (GCC) in Hyderabad by 2030 through its arm Sanofi Healthcare India Pvt Ltd. The initial tranche of Euro 100 million will be invested by 2025 in Hyderabad hub, which Sanofi plans to grow to 2,600 employees by 2026 from 1,000 people currently, Madeleine Roach, executive VP - business operations, Sanofi, said on Wednesday. The new Hyderabad hub, spread over six floors and around 2.8 lakh sq ft at RMZ Spire in Hitech City, is already the largest among Sanofi's network of four GCCs located at Budapest with around 900 employees, and 250 each in Kuala Lumpur and Bogota. Roach said the commitment was part of its strategy to build its business operations and centralised capabilities at the site by hiring talent across R&D, commercial manufacturing and supply, digital and corporate functions. She said Hyderabad hub, set up in 2019, has grown exponentially from being just a medical hub to now providing several best-in-class services to Sanofi's global functions and affiliates across the world. "Hyd will be the largest site with the broadest breadth of capabilities we are building. It is already becoming a site that will truly represent the entire value chain of Sanofi, contributing significantly to our overall operations and strategy. For me, its a microcosm of Sanofi," she said. She termed the new hub as a significant milestone as the company has moved from what is known in GCC parlance as more transactional to truly transformative capabilities. "We are historically a complex organisation that wlll truly benefit from the centralisation we are driving here. We have set a very ambitious agenda to optimise processes and also look at opportunities to also digitalise processes...We are hiring highly talented individuals with medical, scientific and engineering backgrounds and also within corporate functions to drive efficiencies and productivities in the way we work," she explained. Sanofi's executive VP & chief digital officer Emmanuel Frenehard said the Hyderabad hub will play a key role in the company's ambitions to become the first biopharma company powered by Artificial Intelligence (AI) at scale. "We have made a very conscious decision to leverage the capabilities of Hyderabad to bring the competencies that we did not have, into Sanofi. We are not looking at work that we already do. We are looking at doing new work in Hyderabad that sometimes vendors do for us. This kind of work is so uniquely differentiating for Sanofi that it needs to be done by our own employees," he said. He said the company is hiring for profiles that you would generally come across in tech companies like data engineers, data scientists, software engineers, product owners, SCRUM masters.

Sanofi looking to expand India hub with Rs 3.6k-cr push

Hyderabad: French drugmaker Sanofi plans to invest ₹400 million (about ₹3,600 crore) over the next six years to expand its global capability centre (GCC) in Hyderabad by increasing the headcount and further developing the facility. Of the total, ₹100 million will be invested by the end of 2025. Over the next two years, Sanofi plans to more than double the headcount at the Hyderabad GCC to 2,600 employees, making the centre the largest of its four hubs globally. The company employs about 1,000 people in Hyderabad. The Hyderabad GCC will support Sanofi's global operations spanning commercial, manufacturing, supply chain research and development (R&D) and digitalisation. The GCC in India will help the company bring some of outsourced functions in-house, giving it more control over critical operations like manufacturing, commercial and R&D. Established in 2019, Sanofi's Hyderabad GCC is a relatively late entrant to multinational corporations setting up GCCs in India. But, the last one year, the company doubled its headcount in Hyderabad, and expanded from being a medical affairs hub to one providing several best-in-class services to Sanofi's global functions and affiliates across the world. The Hyderabad GCC gained significance as Sanofi undertook massive review to centralise and simplify global operations, allowing the company to redirect resources towards more successful therapeutic areas such as immunology. "We have taken a decision last year, as our next chapter of 'play to win' to double down on building centralised capabilities for Sanofi; within this context, we have chosen Hyderabad as our global hub," said Madeleine Roach, executive vice-president, business operations at Sanofi. Beyond supporting global operations, the Hyderabad GCC will play a key role in creating capabilities in artificial intelligence and digitalisation. Emmanuel Frenehard, executive vice-president and chief digital officer at Sanofi said the company will hire software engineers, data analysts, product engineers and scrum masters. "We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain to harness the pace of scientific discovery, improve our productivity and place better decision intelligence in the hands of our people," Frenehard said. Multinational pharma and medtech companies are setting up GCCs in India to take advantage of talent, especially in the technology domain for bolstering their global operations besides developing AI tools to optimise manufacturing operations, finding drug discovery targets, and simulating clinical trials, among others.

Sanofi Healthcare India to invest €400 million in expanding Hyderabad's GCC

Sanofi Healthcare India Pvt. Ltd. (SHIPL) plans to invest €400 million in capacity expansion of its Global Capability Centre (GCC), Hyderabad including €100 million by 2025. Over the next two years, the GCC will expand to host up to 2600 employees, making it the largest of Sanofi's four global hubs. Sanofi's four GGCC are strategic Hubs across the Globe that give the company a competitive edge in delivering best-in-class enterprise solutions. Established in 2019, the Hyderabad hub has grown exponentially from being a Medical Hub to now providing several best-in-class services to Sanofi's global functions and affiliates across the world. "This future-forward global hub for talent in Hyderabad, is a state-of-the-art workplace designed to be environmentally sustainable and foster diversity and inclusivity." Also read: Sanofi eyes for accelerated growth in India; plans fast-tracking of product pipeline "Hyderabad is emerging as a preferred shared services destination with a large pool of talent. We're excited to invest and build this hub here to become a great global community striving for excellence, with digitalization at the heart of our transformation,'' Madeleine Roach, Executive Vice President, Business Operations, Sanofi told newspersons here on Wednesday. "This substantial additional investment of over 400 million euros and the creation of over 2,600 jobs in the next two years underscore Telangana's commitment to fostering a thriving environment for innovation and growth,'' D Sridhar Babu, Telangnana Minister for Information Technology, Electronics & Communications, Industries & Commerce and Legislative Affairs said. These hubs are key 'nerve-centers' that enable centralization and modernization and allow for scaling-up opportunities across Sanofi's value chain, offering a wide array of services ranging from commercial, manufacturing & supply to R&D and digital. Emmanuel Frenehard, Executive Vice President, Chief Digital Officer, Sanofi said: "Our ambition is to be the first biopharma company powered by Artificial Intelligence (AI) at scale. We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain.'' Also read: Client Associates open office in Kochi for wealth management solutionsSHARE Copy linkEmailFacebookTwitterTelegramLinkedInWhatsAppRedditPublished on July 17, 2024

Sanofi to expand its Global Capacity Centre in Hyderabad

Sanofi carries out more than 60 percent of its global production in the European Union. (Image Credits: Reuters) Sanofi Healthcare India Pvt. Ltd. (SHIPL) on Wednesday announced the expansion of its Global Capacity Centre (GCC) in Hyderabad, with plans to invest €400 million over the next six years, with €100 million by 2025. According to the company's statement, over the next two years, this GCC (hub) will expand to host up to around 2600 employees, making it the largest of Sanofi's four global hubs. "Sanofi's four Global Capacity Centres are strategic Hubs across the Globe that give the company a competitive edge in delivering best-in-class enterprise solutions. These hubs are key 'nerve-centers' that enable centralization and modernization and allow for scaling-up opportunities across Sanofi's value chain, offering a wide array of services ranging from commercial, manufacturing & supply to R&D and digital," the company said in a statement. Established in 2019, the Hyderabad hub has grown exponentially from being a Medical Hub to now providing several best-in-class services to Sanofi's global functions and affiliates across the world. "I thank Hon'ble Minister Sri Duddilla Sridhar Babu for welcoming Sanofi's largest GCC and inaugurating our new workplace. Hyderabad is emerging as a preferred shared services destination with a large pool of talent. We're excited to invest and build this hub here to become a great global community striving for excellence, with digitalization at the heart of our transformation. This hub will be a catalyst enabling Sanofi to accelerate efficiency and reinvent how we work, as we chase the miracles of science to improve people's lives," Madeleine Roach, Executive Vice President, Business Operations, Sanofi said in a statement. This future-forward global hub for talent in Hyderabad is a state-of-the-art workplace designed to be environmentally sustainable and foster diversity and inclusivity, the company claimed. "Our ambition is to be the first biopharma company powered by Artificial Intelligence (AI) at scale. From discovery to treatment, we are using AI ethically and safely to get to market faster with our drugs as there are plenty of unmet needs. We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain to harness the pace of scientific discovery, improve our productivity, and place better decision intelligence in the hands of our people," Emmanuel Frenehard Executive Vice President, Chief Digital Officer, Sanofi said.

French pharma giant Sanofi expands GCC in Hyderabad, to create 1,600 more jobs by 2026

French pharmaceutical giant Sanofi, through one of its entities in India, is expanding its Global Capacity Centre (GCC) in Hyderabad with an investment of Euro 400 million (about Rs. 3,600 crore) spread over six years and create additional 1,600 jobs at the facility in the next two years. The largest among four GCCs of Sanofi globally - Bogota, Columbia; Budapest, Hungary; and Kuala Lumpur, Malaysia host the rest - the facility in Hyderabadhas grown exponentially from a medical hub in 2019 to providing various services to the firm's global functions and affiliates across the world, members of the senior leadership said on Wednesday. In a media interaction, after Industries and IT Minister D. Sridhar Babu opened the new office, in the city's IT Hub, where Sanofi will consolidate the Hyderabad GCC's operations, Executive VP-Business Operations Madeleine Roach said the centre will have a headcount of 2,600 in two years. Transformational work Stating that the GCC recently touched the 1,000 employee mark, she said the hiring will be for different roles, from research and development, commercial, manufacturing, supply chain, digital to corporate functions. It will attract talent from across India and in terms of work, move away from transactional to transformational. "Digitalisation is at the heart of our transformation. This hub will be a catalyst enabling Sanofi to accelerate efficiency and reinvent how we work", she stated in a release. Chief Digital Officer Emmanuel Frenehard said, "We have decided to bring new competencies and new work that sometimes vendors do for us... [going to] lean on Hyderabad for a number of areas and bring in profiles you mostly come across in tech companies data engineers, data scientists, software engineers and scrum masters." Work on AI at scale The ambition is also to be the first biopharma company powered by Artificial Intelligence at scale. "From discovery to treatment, we are using AI ethically and safely to get to market faster with our drugs as there's plenty of unmet needs. We intend to onboard talent at the Hyderabad hub to embrace the power of AI across our value chain", he said. The company estimates Euro 100 million, of the Euro 400, to be invested by next year. Growing prominence of Telangana In the release, the Minister said "expansion of Sanofi's Global Capability Centre in Hyderabad marks a remarkable step forward for Telangana's ever-growing prominence in the global pharmaceutical landscape and commitment to foster a thriving environment for innovation and growth." Read Comments

Sanofi to invest $437 million in India global centre, double its workforce

HYDERABAD (Reuters) - French drugmaker Sanofi plans to invest 400 million euros ($437.24 million) in its global capacity centre (GCC) in India by the end of the decade, as it aims to expand and more than double its workforce over the next two years, a top company executive said on Wednesday. Sanofi will first invest 100 million euros ($109.31 million) by next year, Madeleine Roach, Executive Vice President, Business Operations, said at an event on Wednesday. The GCC, an offshore facility in India's southern city of Hyderabad, is Sanofi's largest globally with an existing workforce of 1,000 employees. The company, which also makes vaccines, has GCCs in Budapest, Malaysia and Colombia. The company aims to increase its strength to 2,600 by 2026, Roach told Reuters on the sidelines of the event. This includes hiring data scientists and data engineers to grow its digital team and effectively use artificial intelligence tools. "Hyderabad's Sanofi staff works very closely with stakeholders in the U.S. and France... the U.S. market has a lot of confidence in the capabilities here," said Roach. The U.S. is Sanofi's largest market by revenue, according to the company. The Hyderabad facility is expected to do a significant amount of documentation work related to drug clinical trials, Roach added. Consulting firm EY estimates India's domestic GCC market size is expected to more than double to $110 billion by 2030, aided by a skilled workforce, and favourable business and policy environment. In addition to the availability of talent in India, Roach also pointed to geopolitical factors for the company's focus on expanding in the country as pharma companies seek to limit their reliance on China. (Reporting by Rishika Sadam in Hyderabad; Editing by Janane Venkatraman)

Sanofi resets footprint in India, Hyd GCC to add new digital competencies

Frenehard spoke of the new capabilities, particularly around leveraging the power of AI. (Image Credits: Reuters) It was a new twist to a narrative from a healthcare company with conversations less about drug-making and more about digital transformation. It should have been expected, coming as it did from French healthcare major Sanofi, which was in the spotlight last year for its new artificial-intelligence app, plai that banks on a large pool of data across Sanofi to provide timely insights and aid decision-making process. Though the meet with journalists organised on Wednesday, July 17, by Sanofi at its new and tony Global Capacity Centre (GCC) in the IT suburb of Hyderabad, was more about the expansion plans for the centre, the senior officials from the company, underlined how it was really about adding new digital competencies. Leading the conversations from Sanofi were Madeleine Roach, executive vice-president, business operations, Sanofi and Emmanuel Frenehard, the company's chief digital officer. Both, aided by Mrinal Duggal, head of the GCC and Rodolfo Hrosz, managing director, Sanofi India, headquartered out of Mumbai. Frenehard spoke of the new capabilities, particularly around leveraging the power of AI. In response to a question from this writer on how this GCC was different from a back office set up by a global pharma company, Frenehard had this to say: "Back offices are usually for transactional support but this is about new solutions that come with a certain level of creativity." Giving examples, he said, it could around efforts to improve yields of a product, or about the readiness with solutions to check deviations (even for instance due to change in temperature) to also help in process improvements. Therefore, the emphasis was not "transactional" abilities but "transformative" capabilities and, as Roach helpfully added: "building a talent pool for the future" and for Sanofi, which she sees as a tech-powered science company. She also referred to efforts towards digitisation as a clear goal with clear KPIs within the company. On the investments made, a note shared by the company said, there were plans to invest in all €400 million (Rs 3600 crore) over the next six years, with €100 million (Rs 900 crore) by 2025. "Over the next two years, this GCC will expand to host up to 2600 employees (currently 1,000), making it the largest of Sanofi's four global hubs." Sanofi's four Global Capacity Centres are strategic Hubs across the Globe (Budapest, Hungary; Bogota, Colombia; Kaula Lumpur, Malaysia; and Hyderabad, India) that give the company a competitive edge in delivering best-in-class enterprise solutions. "These hubs are key 'nervecenters' that enable centralization and modernization and allow for scaling-up opportunities across Sanofi's value chain, offering a wide array of services ranging from commercial, manufacturing & supply to R&D and digital." Established in 2019, the Hyderabad hub has grown from being a medical hub to "now providing several best-in-class services to Sanofi's global functions and affiliates across the world. This future-forward global hub for talent in Hyderabad, is a state-of-the-art workplace designed to be environmentally sustainable and foster diversity and inclusivity," the press release from the company added. Sharing details of the profile of the talent hired thus far at the GCC, Mrinal Duggal said, bulk of them (about 50 per cent) were either PhDs or masters in pharma, about 10 per cent were completely fresh hires from college and about 20 per cent were tech employees hired from engineering colleges. The range of work experience within the GCC was between 1 year and 25 years and the average talent age was about 35 years. Asked about the journey of Sanofi in India thus far and the road ahead, Frenehard said, the company was "resetting the footprint in India and stepping up its value accretive activities" with the GCC playing a crucial role in this journey.